Buscar
25/03/2026
Adherence to Barrett's esophagus surveillance guidelines and its impact on progression: a multicenter prospective study
Murzi-Pulgar, M, Huerta, A, Sánchez-Montes, C, Hernández, L, Cajal, MD, Nicolas-Perez, D, Gamarro, MP, Aicart-Ramos, M, Lira, A, Gallardo, NM, Vicente, JL, Ruiz-Ramírez, P, Oblitas, E, Huertas, C, Garcia, EN, Iborra, G, Núñez-Pizarro, JL, Argüello-Viudez, L, Aisa, ACP, Fernández, ED, Loras, C, Uchima, H, Giordano, A, Guarner-Argente, C, Fernández-Esparrach, G. Adherence to Barrett's esophagus surveillance guidelines and its impact on progression: a multicenter prospective study. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-026-44028-z. PMID:41882169. IF:3.900(Q1/2D).
24/03/2026
Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups
Rivera-Pérez, C, Morgades, M, Alonso-Saladrigues, A, Montesinos, P, Murciano, T, Gil, C, Adán, R, Esteve, J, Fuentes, C, Amigo, ML, González-Martínez, B, Coll, R, Dapena, JL, De Llano, MPQ, Fuster, JL, García-Cadenas, I, Tasso, M, Barba, P, Rives, S, Ribera, JM. Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups. ANNALS OF HEMATOLOGY. 2026; 105(4)DOI:10.1007/s00277-026-06956-8. PMID:41874722. IF:2.400(Q2/5D).
24/03/2026
Prenatal Exposure to Mixtures of Nonpersistent Endocrine-Disrupting Chemicals and Angiogenic Biomarkers, Placental Function, and Fetal Growth
Knox, B, Guil-Oumrait, N, Midya, V, Vespalcova, H, Gomez-Roig, MD, Llurba, E, Marquez, S, Ruiz, ZG, Galmes, T, Philippat, C, Sakhi, AK, Thomsen, C, Urquiza, J, Zanini, MJ, Dadvand, P, Gascon, M, Rivas, I, Foraster, M, Basagana, X, Sunyer, J, Bustamante, M, Vrijheid, M. Prenatal Exposure to Mixtures of Nonpersistent Endocrine-Disrupting Chemicals and Angiogenic Biomarkers, Placental Function, and Fetal Growth. ENVIRONMENTAL SCIENCE & TECHNOLOGY. 2026; 60(11)DOI:10.1021/acs.est.5c13234. PMID:41801018. IF:11.300(Q1/1D).
24/03/2026
Patient-reported outcome measures for technology assessment: A comparison between three-dimensional conformal and intensity-modulated radiotherapy in prostate cancer
Mera, A, Sancho, G, Garin, O, Pont, A, Pardo, Y, Macias, V, Hervas, A, Cabrera, P, Ferrer, F, Roselló, A, Ots, PS, García, ME, Jové-Teixidó, J, Ferrer, M. Patient-reported outcome measures for technology assessment: A comparison between three-dimensional conformal and intensity-modulated radiotherapy in prostate cancer. World Journal Of Clinical Oncology. 2026; 17(3)DOI:10.5306/wjco.v17.i3.115774. PMID:. IF:(Q/D).